ethinyl estradiol has been researched along with Disease Exacerbation in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Heo, JH; Hong, EJ; Jeong, SH; Jo, SL; Ko, JW; Kwun, HJ; Lee, SR | 1 |
| Iijima, M; Iwamoto, H; Izumi, K; Kadono, Y; Kawaguchi, S; Mizokami, A; Nakano, T; Nohara, T; Shigehara, K; Yaegashi, H | 1 |
| Chabbert-Buffet, N; Daraï, E; Geoffron, S; Legendre, G | 1 |
| Alfarone, A; Cattarino, S; D'Eramo, G; Gentile, V; Gentilucci, A; Salciccia, S; Sciarra, A | 1 |
| Brynhildsen, J; Hammar, M; Kempe, P | 1 |
| Asamoto, M; Cho, YM; Hokaiwado, N; Inaguma, S; Shirai, T; Suzuki, S; Takahashi, S | 1 |
| Di Silverio, F; Sciarra, A | 1 |
| Bok, R; Bubley, GJ; Derynck, MK; DiPaola, RS; Jones, G; Kantoff, PW; Oh, WK; Rini, BI; Rosen, RT; Small, EJ; Smith, MR; Weinberg, V | 1 |
| Apelgren, LD; Bailey, DL; Bryan, N; Bumol, TF; Evans, GF; Fouts, RL; Glasebrook, A; Sandusky, GE; Short, L; Zuckerman, SH | 1 |
1 review(s) available for ethinyl estradiol and Disease Exacerbation
| Article | Year |
|---|---|
[Medical treatment of endometriosis: Hormonal treatment of pain, impact on evolution and future perspectives].
Topics: Disease Progression; Drug Combinations; Endometriosis; Ethinyl Estradiol; Female; Forecasting; Gonadotropin-Releasing Hormone; Humans; Norpregnenes; Pain Management; Pelvic Pain; Pelvis; Progestins | 2017 |
1 trial(s) available for ethinyl estradiol and Disease Exacerbation
| Article | Year |
|---|---|
Prospective, multicenter, randomized phase II trial of the herbal supplement, PC-SPES, and diethylstilbestrol in patients with androgen-independent prostate cancer.
Topics: Administration, Oral; Aged; Aged, 80 and over; Androgens; Anticoagulants; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Complementary Therapies; Cross-Over Studies; Diethylstilbestrol; Disease Progression; Drug Contamination; Drugs, Chinese Herbal; Estradiol Congeners; Ethinyl Estradiol; Humans; Male; Middle Aged; Prospective Studies; Prostatic Neoplasms; Reproducibility of Results; Treatment Outcome; Warfarin | 2004 |
7 other study(ies) available for ethinyl estradiol and Disease Exacerbation
| Article | Year |
|---|---|
Dietary Intake of 17α-Ethinylestradiol Promotes HCC Progression in Humanized Male Mice Expressing Sex Hormone-Binding Globulin.
Topics: Androgens; Animals; Carcinoma, Hepatocellular; Diethylnitrosamine; Disease Models, Animal; Disease Progression; Ethinyl Estradiol; Humans; Liver Neoplasms; Male; Mice; Sex Characteristics; Sex Hormone-Binding Globulin | 2021 |
Therapeutic Effect of Ethinylestradiol in Castration-resistant Prostate Cancer.
Topics: Aged; Aged, 80 and over; Disease Progression; Ethinyl Estradiol; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Retrospective Studies; Treatment Outcome | 2020 |
Oral ethinylestradiol in castration-resistant prostate cancer: a 10-year experience.
Topics: Administration, Oral; Aged; Antineoplastic Agents, Hormonal; Disease Progression; Ethinyl Estradiol; Follow-Up Studies; Humans; Italy; Male; Middle Aged; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Survival Analysis; Treatment Outcome | 2015 |
Symptoms of multiple sclerosis during use of combined hormonal contraception.
Topics: Adult; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Diagnostic Self Evaluation; Disease Progression; Estrogens; Ethinyl Estradiol; Female; Humans; Multiple Sclerosis; Progestins; Prospective Studies; Symptom Assessment; Young Adult | 2015 |
Age-dependent histopathological findings in the prostate of probasin/SV40 T antigen transgenic rats: lack of influence of carcinogen or testosterone treatment.
Topics: Adenocarcinoma; Age Factors; Aminobiphenyl Compounds; Androgen Antagonists; Androgen-Binding Protein; Animals; Animals, Genetically Modified; Antigens, Polyomavirus Transforming; Carcinogens; Disease Progression; Drug Implants; Ethinyl Estradiol; Heterozygote; Imidazoles; Ki-67 Antigen; Male; Mammary Neoplasms, Experimental; Neoplasm Proteins; Orchiectomy; Phenotype; Prostate; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Rats; Rats, Sprague-Dawley; Receptors, Androgen; Testosterone; Tongue Neoplasms | 2003 |
Combination therapy of ethinylestradiol and somatostatin analogue reintroduces objective clinical responses and decreases chromogranin a in patients with androgen ablation refractory prostate cancer.
Topics: Administration, Oral; Aged; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Bone Neoplasms; Chromogranin A; Chromogranins; Disease Progression; Drug Therapy, Combination; Ethinyl Estradiol; Follow-Up Studies; Humans; Injections, Intramuscular; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Peptides, Cyclic; Prostate-Specific Antigen; Prostatic Neoplasms; Somatostatin | 2003 |
The effect of a selective estrogen receptor modulator on the progression of spontaneous autoimmune disease in MRL lpr/lpr mice.
Topics: Animals; Autoimmune Diseases; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Disease Models, Animal; Disease Progression; Estradiol Congeners; Estrogen Antagonists; Ethinyl Estradiol; Female; Kidney; Lupus Erythematosus, Systemic; Lymph Nodes; Mice; Mice, Inbred MRL lpr; Molecular Structure; Pyrrolidines; Receptors, Estrogen; Thiophenes; Thymus Gland | 1996 |